BofA lowered the firm’s price target on Camtek (CAMT) to $128 from $135 and keeps a Buy rating on the shares. The company reported Q3 sales and EPS ahead of the Street, while the Q4 outlook is effectively in-line, the analyst tells investors in a research note. The firm added, however, that it senses increasing confidence that the ramp in 2H26 will be particularly steep across both HBM and chiplet businesses as customers prepare capacity for outsized, multi-year AI-infra buildouts.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAMT:
- Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
- Morning Movers: Monday.com sinks following third quarter results
- Camtek Reports Record Q3 2025 Results and Positive Outlook
- Camtek CEO sees FY26 revenues ‘more second half weighted’
- Camtek reports Q3 non-GAAP EPS 82c, consensus 80c